Fisher & Paykel Healthcare Corporation Limited

FSPKFOTCHealthcare● Active

$22.52

+$0.00(+0.00%)

Market Cap$13.2B

P/E Ratio—

52W High$25.69

52W Low$16.35

Avg Volume311

Open$22.52

Beta0.89

Overview

Fisher & Paykel Healthcare Corporation Limited（FSPKF）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

fspkf · 股价预测 · 0 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 0 位华尔街分析师

N/A

0 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 0 · 买入占比: 0.0%

12 个月目标价

High

$26.00

Consensus

$23.65

+5.0% upside

Low

$21.30

Median: $23.65 · Last Close: $22.52

Fisher & Paykel Healthcare Corporation Limited（FSPKF）的分析师共识为 N/A，基于过去 3 个月内 0 位华尔街分析师的评级。FSPKF 的 12 个月平均目标价为 $23.65，相对当前价 $22.52 代表 +5.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $24 (5.0%)High $26Low $21.3

Consensus Target

$23.65

5.0% upside

High Target

$26

15.5%

Low Target

$21.3

-5.4%

Current Price

$22.52

as of today

Based on analyst price targets, the FSPKF stock price prediction for the next 12 months ranges from $21.3 to $26. The consensus FSPKF price forecast of $23.65 implies 5.0% upside from the current price of $22.52.

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-10	$22.33	↓ 0.85%	$22.22	$22.44

1-day model range: $22.22–$22.44. Peak: $22.44 (-0.85%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$23	$24	$25	+6.2%
2028	$24	$25	$26	+10.4%
2029	$24	$26	$27	+13.3%
2030	$25	$26	$27	+15.2%
2031	$25	—	$28	+16.5%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

79%0%21%

11Buy

0Neutral

3Sell

RSI (14)100.0Overbought

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · FSPKF · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$20.94BUY

MA 10$20.75BUY

MA 20$21.02BUY

MA 50$22.22BUY

MA 100$22.61SELL

MA 200$21.67BUY

Current $FSPKF · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$21.21BUY

EMA 10$20.99BUY

EMA 20$21.19BUY

EMA 50$21.83BUY

EMA 100$22.03BUY

EMA 200$21.75BUY

Current $FSPKF · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

分析师推荐趋势

FSPKF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$2.3B

↓ 20.4% YoY

Revenue Next Year

$2.6B

↑ 12.7% YoY

EPS This Year

$0.80

EPS Next Year

$0.95

↑ 18.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast FSPKF EPS of $0.80 for the current fiscal year, based on estimates from 1 analysts. The FSPKF revenue forecast is $2.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

FSPKF 股价预测由两类独立数据源支撑：来自 0 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。FSPKF 的共识目标价为 $23.65（+5.0% 上行空间），分析师共识为 N/A。

FSPKF 的短期预测（明日）为 $22.33（-0.85%）。 FSPKF 对 2027 年的股价预测均值为 $24。 FSPKF 对 2030 年的预测区间为 $25–$27。

Fisher & Paykel Healthcare Corporation Limited 在 OTC 上市，代码 FSPKF。FSPKF 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 0% 对应 N/A 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

FSPKF 预测 · 8 个问题

根据 0 位华尔街分析师，FSPKF 的 12 个月平均目标价为 $23.65，最高 $26.00、最低 $21.30。若有图表，中位目标价可在上方查看。相对当前价 $22.52，隐含约 +5.0% 的上行空间。

FSPKF 目标价FSPKF 分析师目标价FSPKF 12个月目标价目标价 FSPKF

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.